Ondansetron Injection, Solution
Product Images NDC 76045-103

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 76045-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ond06 0005 01

Ond06 0005 01
Chemical structure of ondansetron hydrochloride dihydrate depicted as a molecular diagram, showing the arrangement of atoms and rings in the compound.*
FDA Label Image

Ond06 0005 02

Ond06 0005 02
An instructional diagram showing the components of a prefilled syringe for Ondansetron injection, solution 4 mg/2 mL. The illustration labels parts including the outer package, plunger rod, syringe barrel, label with a note not to remove, Luer lock collar with a note not to remove, and syringe tip cap.*
FDA Label Image

Ond06 0005 03

Ond06 0005 03
An instructional illustration showing hands opening the sealed packaging of a prefilled syringe, presumably containing ondansetron hydrochloride injection solution. The image demonstrates the initial step of accessing the injection device.*
FDA Label Image

Ond06 0005 04

Ond06 0005 04
An instructional illustration showing two hands removing the cap from the vial of Ondansetron Injection, Solution. The image depicts the action of twisting and pulling to open the vial top for use.*
FDA Label Image

Ond06 0005 05

Ond06 0005 05
The image shows a rectangular drug product label for Ondansetron 4 mg/2 mL Injection, Solution. The label includes the proprietary name ONDANSETRON and identifies the active ingredient as ondansetron hydrochloride. The product is an injection solution intended for intramuscular and intravenous use. The labeler is Fresenius Kabi USA, LLC, located in Lake Zurich, IL 60047. The label includes branding with the Fresenius Kabi logo.*
FDA Label Image

Ond06 0005 06

Ond06 0005 06
Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) injection solution for intravenous or intramuscular use. The label indicates a package containing 24 prefilled single-use 2 mL syringes by Fresenius Kabi USA, LLC. The label includes dosage strength, usage instructions, and barcodes.*
FDA Label Image

Ond06 0005 07

Ond06 0005 07
Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) in a 2 mL prefilled single-use syringe. The label indicates it is for IV or IM use and includes instructions about storage, dosage, and dilution precautions. The labeler is Fresenius Kabi USA, LLC, and the label features a barcode, lot number, and expiration date fields.*
FDA Label Image

Ond06 0005 08

Ond06 0005 08
Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) single-use vial label for intravenous or intramuscular administration. The label includes a volume scale from 0.5 mL to 2 mL and states dilution is required for chemotherapy-induced nausea and vomiting. The product is labeled by Fresenius Kabi USA, LLC and marked Rx only.*
FDA Label Image

Ond06 0005 09

Ond06 0005 09
Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) prefilled single-use syringes carton, labeled for intravenous or intramuscular use. Package contains 24 syringes. The label includes handling instructions and Fresenius Kabi USA, LLC as the labeler.*
FDA Label Image

Ond06 0005 10

Ond06 0005 10
Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) in a 2 mL prefilled single-use syringe for intravenous or intramuscular use. Label includes dosing caution for chemotherapy-induced nausea and vomiting, storage instructions, and barcodes. Manufactured by Fresenius Kabi USA, LLC, branded as Simplist.*
FDA Label Image

Ond06 0005 11

Ond06 0005 11
Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) solution for injection, labeled for intravenous or intramuscular use, single 2 mL dose. The label includes a volume scale up to 2 mL, bar code, and a red warning box stating "Dilution required for chemotherapy induced nausea and vomiting." Labeler is Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.